Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tremor in multiple sclerosis.

Marcus Koch1, Jop Mostert, Dorothea Heersema

  • 1Department of Neurology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. m.w.koch@neuro.umcg.nl

Journal of Neurology
|February 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

European journal of neurology·2026
Same author

Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

Neurology·2026
Same author

The Pivotal Step of Structure Formation and Oil-Binding Capacity of Polyglucosamine.

Polymer science & technology (Washington, D.C.)·2026
Same author

Extracellular vesicles derived from Enterococcus faecalis: inflammatory activation does not require internalization.

Cell communication and signaling : CCS·2026
Same author

The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosis.

Journal of neurology·2026
Same author

A multivalent TAT-arginine-biodynamer conjugate targeting the bacterial cell envelope via specific membrane interactions.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Multiple sclerosis (MS) tremor affects many patients and is challenging to treat. Current treatments offer limited relief, highlighting the need for more research into effective MS tremor management strategies.

Area of Science:

  • Neurology
  • Neuroscience
  • Clinical Medicine

Background:

  • Tremor affects 25-60% of multiple sclerosis (MS) patients.
  • MS tremor is disabling and difficult to manage effectively.
  • Limited evidence supports current pharmacological and surgical interventions.

Purpose of the Study:

  • To review the current state of MS tremor management.
  • To identify gaps in research and clinical practice.
  • To highlight the unmet need for effective tremor therapies in MS.

Main Methods:

  • Literature review of existing studies on MS tremor treatments.
  • Analysis of reported effectiveness and limitations of various interventions.
  • Assessment of surgical and non-pharmacological approaches.

Related Experiment Videos

Main Results:

  • High-dose isoniazid, carbamazepine, propranolol, and gluthetimide show limited evidence of effectiveness.
  • Cannabinoids appear ineffective for MS tremor.
  • Stereotactic thalamotomy and thalamic stimulation offer tremor reduction but lack long-term outcome data.
  • Physiotherapy, orthoses, and limb cooling provide some functional improvement.

Conclusions:

  • MS tremor remains a significant clinical challenge with unmet therapeutic needs.
  • Further basic and clinical research is essential for developing better treatments.
  • Improved management strategies are crucial for enhancing the quality of life for MS patients.